
Is Anavar Liver Toxic? Enzymes, Milk Thistle vs NAC vs TUDCA, and What Protects You
The Mildest Oral Is Still an Oral
Is Anavar liver toxic? Yes, measurably, in virtually every user, at every dose. Oxandrolone is the gentlest 17-alpha-alkylated oral on the liver, and "gentlest" still means ALT and AST rise in nearly every blood panel taken on cycle, including at the 20 mg therapeutic dose in the clinical trials. The question that matters is not whether oxandrolone affects the liver but how much, for how long, and what actually reduces it.
Milk thistle is the supplement most users reach for first, and this guide starts there because the short answer is more complicated than the label suggests: silymarin has real hepatoprotective mechanisms and almost no evidence for the specific job it is being asked to do. From there it covers what the enzymes actually look like on cycle, how NAC and TUDCA compare, the tiered protection protocol the community has settled on, and the lifestyle factors that move the numbers more than any capsule. It is the liver companion to the Anavar cycle guide and the side effects page.
Anavar liver toxicity is dose- and duration-dependent and reversible at normal cycle lengths. The users who get into trouble are the ones who drink on cycle, run past eight weeks, or stack a second oral on top.
Why Anavar Stresses the Liver and What the Enzymes Show
Oxandrolone is a 17-alpha-alkylated oral. The 17-aa modification is what stops the liver from destroying the compound on first pass so it can reach muscle; the trade-off is that the liver has to process a molecule it cannot efficiently metabolise, and the hepatic strain shows up in the enzymes. So is Anavar liver toxic in practice? On a standard male cycle of 40 to 60 mg, ALT and AST typically rise to two to three times baseline, GGT rises mildly in some users, and bilirubin usually stays in range. Oxandrolone's particular advantage is that it is less hepatotoxic than any other 17-aa oral at equivalent doses, Winstrol runs three to five times baseline, Anadrol five to ten, and clinical courses of twelve weeks at therapeutic doses have not impaired liver function.
Anavar liver enzymes on cycle (men, 40 to 60 mg, all normal at baseline)
ALT
1.5 to 2.5×
2 to 3×
Normalising
AST
1.5 to 2.5×
2 to 3×
Normalising
GGT
Mild rise in some
Mild rise
Normal
Bilirubin
Normal
Usually normal
Normal
Recovery to baseline takes four to eight weeks after the last dose, which is why the Anavar results timeline includes a post-cycle panel. Women at 5 to 10 mg see the same pattern at smaller magnitude; the Anavar side effects in women guide has the female numbers.
Milk Thistle and Anavar: What It Does and Does Not Do
Milk thistle (Silybum marianum) contains silymarin, a group of flavonoids, silybin the most active, with documented antioxidant, anti-inflammatory and regenerative effects on liver cells. It scavenges the free radicals produced by drug metabolism, inhibits the NF-kB inflammatory pathway in liver tissue, stimulates protein synthesis in hepatocytes and may raise glutathione. Those mechanisms are real and supported in controlled settings: silymarin has shown hepatoprotective effects in trials on alcoholic liver disease, hepatitis and drug-induced liver injury, and in animal models it reduces enzyme elevation from hepatotoxic compounds.
What the research does not support is the specific use. No clinical trial has studied milk thistle and Anavar, or milk thistle during any anabolic steroid cycle. The doses that worked in the liver-disease trials, 420 to 600 mg of silymarin daily, are often higher than a standard supplement provides. Oral silymarin's bioavailability is poor, with only 20 to 50% absorbed and much of that rapidly metabolised. And the cholestatic stress that 17-aa steroids produce may simply exceed what silymarin at supplement doses can neutralise. Community experience reflects that gap: some users report lower enzymes on cycles with milk thistle, others report identical elevations with and without it, and the variation in dose, length and individual response makes the anecdotes unreliable either way.
The fair verdict on milk thistle and Anavar is that silymarin is a legitimate mild hepatoprotectant that is asked to do a job it was never tested for.
Milk Thistle vs NAC vs TUDCA
The community has largely moved past milk thistle as the primary liver support on an oral cycle, and two alternatives have stronger evidence.
NAC (N-acetylcysteine) is a precursor to glutathione, the liver's most important endogenous antioxidant, it replenishes the compound the liver actually uses to defend itself rather than supplying an external one. It is used in hospitals to treat paracetamol overdose, which is proof that it works under severe acute hepatotoxic stress; its bioavailability is far better than silymarin's; the effective dose is well established at 1,200 mg daily split morning and evening; and it is cheap. It is the r/steroids standard for any oral cycle.
TUDCA (tauroursodeoxycholic acid) is a bile acid that protects liver cells against cholestatic stress, the disruption of bile flow that is the specific mechanism of 17-aa steroid liver injury. It has clinical evidence in cholestatic conditions, which makes it the most directly relevant of the three, and community blood-work comparisons consistently show lower enzyme elevations on TUDCA than on milk thistle. The standard dose is 500 mg daily during the cycle. Its drawbacks are cost, $30 to 50 a month against $10 to 15, and that it should not be run continuously off-cycle, because it alters bile composition without a reason to.
Liver support compared
Milk thistle
Antioxidant, anti-inflammatory
Weak; no steroid trials, poor absorption
400 to 600 mg silymarin; $10 to 15
NAC
Glutathione precursor
Strong; proven in acute hepatotoxicity
1,200 mg split; $10 to 20
TUDCA
Bile-acid protection against cholestasis
Strong; targets the 17-aa mechanism
500 mg; $30 to 50
The consensus that follows: NAC at 1,200 mg daily is the minimum for any oxandrolone cycle, TUDCA at 500 mg is the upgrade above 60 mg or beyond six weeks, and milk thistle alone is considered insufficient by most experienced users for 17-aa oral use.
"Anyone can swing wild and burn out in the first round. The ones who last plan every move before the bell, they know exactly when to push and when to stop.", Jack Hanma
Liver protection is the part of the plan that is decided before the first tablet, not after the week-four panel.
Where Milk Thistle Still Fits
Milk thistle is not useless; it is mis-assigned. Between cycles, in the recovery phase, its milder protection is proportionate to the lower hepatic stress, it can be taken continuously without the concerns that attach to long-term TUDCA, and 400 to 600 mg of standardised silymarin daily is a reasonable off-cycle habit. On cycle, some users stack it with NAC as an additional antioxidant layer, the two do not interact, the cost is trivial, and the mechanisms are complementary. And for the mildest scenarios, a woman at 5 to 10 mg, a man at 30 to 40 mg for six weeks or less, milk thistle provides baseline protection that is arguably enough. Above 50 mg, beyond six weeks, or with any second oral in the picture, NAC or TUDCA is strongly preferred.
The Tiered Liver Protection Protocol
Community consensus and the available research produce a three-tier structure that scales with dose. Tier one, the minimum for every oxandrolone cycle: NAC 1,200 mg daily as 600 mg morning and evening, zero alcohol through the cycle and for two weeks after, blood work at week four, and at least three litres of water a day. Tier two, for doses above 50 mg or cycles of seven to eight weeks: TUDCA 500 mg daily with meals and at least two hours apart from the NAC, NAC continued, milk thistle at 400 mg as an optional extra antioxidant, and blood work at weeks four and six. Tier three, for doses above 80 mg or any stack with a second hepatotoxic compound, which the stacking guide argues against, TUDCA 500 to 750 mg, NAC 1,200 to 1,800 mg, blood work at weeks three and six, and a hard rule that ALT or AST above five times baseline means reducing the dose or stopping.
The post-cycle phase is part of the protocol, not an afterthought:
- 1Continue NAC at 600 to 1,200 mg daily for four weeks after the last dose
- 2Switch to milk thistle at 400 to 600 mg once enzymes have normalised, if any support is wanted at all
- 3Confirm recovery with a liver panel six to eight weeks post-cycle
- 4Do not start another hepatotoxic oral until enzymes are back at baseline
What Protects the Liver More Than Any Supplement
Supplements are one layer of the answer to whether Anavar is liver toxic for a given user; lifestyle is the bigger one. Alcohol is the single most important variable. Even moderate drinking on oxandrolone compounds hepatotoxicity sharply, community blood-work posts consistently show two to three times higher enzyme elevations in users who drank during the cycle than in abstainers, and "I only had two beers" is the most common preamble to an alarming panel in the Reddit threads. Zero alcohol on cycle is worth more than any capsule.
Diet contributes: cruciferous vegetables support liver detoxification pathways, adequate protein supports repair, and processed food, excess sugar and trans fats add metabolic load on top of the compound. Coffee at two to three cups a day has documented hepatoprotective effects in clinical research and is the one indulgence the liver approves of. Hydration at three litres or more supports bile flow and clearance, and dehydration concentrates hepatotoxic metabolites. Dose and length remain the first and largest levers, the Anavar and test cycle guide shows how the oral portion is kept to six to eight weeks inside a longer injectable run for exactly this reason.
Frequently Asked Questions
Yes, measurably, in nearly every user. As a 17-alpha-alkylated oral it raises ALT and AST to two to three times baseline on a standard cycle, though it is the least hepatotoxic oral in common use and twelve-week clinical courses have not impaired liver function. The effect reverses within four to eight weeks of stopping.
Only modestly. Silymarin has real antioxidant mechanisms and evidence in liver disease, but no trial has tested it during a steroid cycle, its absorption is poor, and supplement doses sit below the ones that worked clinically. It is reasonable off-cycle or as an add-on; NAC and TUDCA are the primary options on cycle.
NAC at 1,200 mg daily is the minimum for any cycle, cheap and well proven. TUDCA at 500 mg targets the cholestatic mechanism of 17-aa injury directly and produces lower enzyme readings in community comparisons, so it is the upgrade above 60 mg, beyond six weeks or with any second oral.
Recreational cycles stay at six to eight weeks because enzymes keep rising past that point without matching benefit; the label supports two- to four-week courses with repeats under monitoring. Actual liver damage at normal cycle lengths is rare; the risk climbs with alcohol, stacking and cycles beyond eight weeks.
On the liver side, ALT and AST rise two to three times baseline by weeks six to eight, GGT rises mildly in some users, and bilirubin usually stays normal. Alongside that, HDL falls 30 to 50%, LDL rises, SHBG drops 40 to 60% and, without a testosterone base, LH, FSH and testosterone are suppressed by week four.
It is the worst thing a user can do for the liver on cycle. Community blood work shows two to three times higher enzyme elevations in users who drank, and the recurring alarming-panel post starts with "I only had a couple". The rule is zero alcohol during the cycle and for two weeks after.
This article is for educational and harm-reduction purposes only and is not medical advice. Oxandrolone is a prescription-only or controlled substance in most countries; anyone considering it should consult a licensed physician.
Anavar.org is an independent educational resource. We are not affiliated with any pharmaceutical manufacturer or healthcare provider. This content is for informational purposes only and does not constitute medical advice. Images on this site are illustrative artwork made for editorial purposes; they do not show real products, packaging or labels and are not an advertisement or an offer to sell.
Editorial
Author
Comments (0)
Be the first to comment on this article.


